R
Richard C O'Brien
Researcher at University of Melbourne
Publications - 77
Citations - 3602
Richard C O'Brien is an academic researcher from University of Melbourne. The author has contributed to research in topics: Diabetes mellitus & Albuminuria. The author has an hindex of 29, co-authored 75 publications receiving 3285 citations. Previous affiliations of Richard C O'Brien include Austin Hospital & The Heart Research Institute.
Papers
More filters
Journal ArticleDOI
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Russell S. Scott,Richard C O'Brien,Greg Fulcher,Chris Pardy,Michael C d'Emden,Dana Tse,Marja-Riitta Taskinen,Christian Ehnholm,Anthony C Keech +8 more
TL;DR: Metabolic syndrome components identify higher CVD risk in individuals with type 2 diabetes, so the absolute benefits of fenofibrate are likely to be greater when metabolic syndrome features are present.
Journal ArticleDOI
Familial hypercholesterolaemia: a model of care for Australasia.
Gerald F. Watts,David R. Sullivan,Nicola K. Poplawski,Frank M. van Bockxmeer,Ian Hamilton-Craig,Peter M. Clifton,Richard C O'Brien,Warrick Bishop,Peter M. George,Philip J. Barter,Timothy R. Bates,John R. Burnett,John Coakley,Patricia M. Davidson,Jon Emery,Andrew J. Martin,Waleed O Farid,Lucinda Freeman,Elizabeth Geelhoed,A. Juniper,A. Juniper,Alexa Kidd,Karam Kostner,Ines Krass,Michael Livingston,Suzy Maxwell,Peter O'Leary,Amal Owaimrin,Trevor G. Redgrave,Nicola Reid,L. Southwell,Graeme Suthers,Andrew Tonkin,Simon C B Towler,Ronald J. Trent +34 more
TL;DR: The FH Australasia Network (Australian Atherosclerosis Society) has developed a consensus model of care (MoC) for FH, which aims to provide a standardised, high-quality and cost-effective system of care that is likely to have the highest impact on patient outcomes.
Journal ArticleDOI
Long-Term Estrogen Therapy Improves Vascular Function in Male to Female Transsexuals
Gishel New,K L Timmins,Stephen J. Duffy,Binh T. Tran,Richard C O'Brien,Richard W. Harper,Ian T. Meredith +6 more
TL;DR: In this paper, the effects of long-term estrogen therapy on vascular function in male to female transsexuals and to compare the findings with those observed in men and premenopausal women were examined.
Journal ArticleDOI
Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery
Susan J Wigg,Marianne Tare,Mary A Tonta,Richard C O'Brien,Ian T Meredith,Helena C. Parkington +5 more
TL;DR: No-dependent responses are preserved in diabetes, whereas endothelial responses-dependent upon EDHF appear to be impaired, and the putative channels responsible for mediating the EDHF response may be altered in diabetes.
Journal Article
Long-term estrogen therapy improves vascular function in male to female transsexuals (see comments)
Gishel New,K L Timmins,Stephen J. Duffy,Binh T. Tran,Richard C O'Brien,Richard W. Harper,Ian T. Meredith +6 more
TL;DR: Long-term estrogen therapy appears to improve vascular function in male to female transsexuals and occurs despite higher triglyceride levels and the presence of small, dense LDL-C.